Interview with CytImmune CEO Saba Malak

HealthBiz with David E. Williams

English - June 17, 2021 12:00 - 32 minutes - 22 MB - ★★★★★ - 42 ratings
Management Business healthcare business health care healthcare policy entrepreneurship ceo interview Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Interview with Curation Health CEO Kevin Coloton

Next Episode: Interview with Glympse Bio CEO Caroline Loew

CytImmune Sciences is an emerging leader in cancer nanomedicine. It is a platform company with products of its own in development. CEO Saba explains the technology and why he is confident it will ultimately help patients. The company has a Phase II development collaboration with the National Cancer Institute, and is scaling up its manufacturing to be ready.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.